Share Price and Basic Stock Data
Last Updated: December 9, 2025, 9:44 pm
| PEG Ratio | -3.43 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Supreme Petrochem Ltd operates in the petrochemicals sector, primarily focusing on polymers. As of the latest reporting, the company’s share price stood at ₹628, with a market capitalization of ₹11,817 Cr. Revenue trends have shown fluctuations over the past year, with sales peaking at ₹1,573 Cr in June 2024, before tapering to ₹1,506 Cr in September 2024. The trailing twelve months (TTM) revenue reached ₹5,836 Cr, a testament to the company’s resilience amid volatile market conditions. Notably, revenue from operations has shown a compound growth trajectory, increasing from ₹5,032 Cr in FY 2022 to ₹6,023 Cr in FY 2025, highlighting a robust demand for its products. However, the revenue growth isn’t without its challenges, as quarterly sales have experienced dips, raising questions about demand sustainability and potential market pressures.
Profitability and Efficiency Metrics
When it comes to profitability, Supreme Petrochem has reported mixed results. The operating profit margin (OPM) has fluctuated, peaking at 17% in June 2022 but declining to around 8% in the most recent quarters. The net profit for FY 2025 was recorded at ₹391 Cr, down from ₹498 Cr in the previous fiscal year, indicating pressure on margins despite stable sales figures. The company maintains a healthy return on equity (ROE) of 17.4% and return on capital employed (ROCE) of 22.8%, which suggest efficient utilization of capital. However, the interest coverage ratio (ICR) stands impressively at 48.80x, providing a cushion against financial distress. This buffer indicates that while profitability metrics may be under pressure, the company is in a strong position to service its debt obligations comfortably.
Balance Sheet Strength and Financial Ratios
Supreme Petrochem’s balance sheet reflects a solid financial foundation, with total reserves reaching ₹2,182 Cr and borrowings relatively low at ₹140 Cr. This conservative leverage is commendable, especially in an industry often characterized by higher debt levels. The company’s current ratio is a healthy 1.91, suggesting it has adequate liquidity to cover short-term obligations. Furthermore, the price-to-book value (P/BV) ratio of 5.29x may imply that the stock is trading at a premium; however, this is not uncommon in the petrochemical sector where growth prospects are factored in. On the efficiency front, the cash conversion cycle (CCC) stands at just 8 days, indicating effective management of working capital. However, the declining trend in operating profit margins raises concerns about cost management and competitive pricing strategies in the future.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Supreme Petrochem reveals a strong promoter holding of 64.24%, which can instill confidence among investors regarding management’s commitment to the company’s long-term vision. Foreign institutional investors (FIIs) have gradually increased their stake from 2.14% in December 2022 to 3.69% by September 2025, reflecting growing confidence in the company’s prospects. Domestic institutional investors (DIIs) have also raised their holdings, now at 3.87%. However, the public shareholding has seen a decline, dropping to 28.10%, which could suggest a potential lack of retail investor interest. With 46,388 shareholders, the company has a diverse base, yet the declining public participation might indicate caution among smaller investors, possibly due to the recent volatility in profitability.
Outlook, Risks, and Final Insight
Looking ahead, Supreme Petrochem faces a mixed bag of opportunities and risks. The strong demand for petrochemical products and a robust balance sheet provide a solid foundation for growth. However, the declining profitability margins and fluctuating sales figures raise concerns about operational efficiency and market competition. Investors should be wary of external factors such as raw material price volatility and regulatory changes that could impact margins. The company’s ability to navigate these challenges will be crucial for maintaining investor confidence. As Supreme Petrochem continues to adapt to the evolving market landscape, it remains imperative for investors to keep a close watch on both its operational performance and macroeconomic indicators that could influence the petrochemical sector. Overall, while the fundamentals appear strong, the road ahead may require strategic agility and prudent financial management.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Supreme Petrochem Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Fluoro Carbons Ltd | 31.4 Cr. | 16.0 | 19.6/10.8 | 262 | 41.8 | 0.00 % | 1.02 % | % | 10.0 |
| Gujarat Petrosynthese Ltd | 35.8 Cr. | 60.0 | 81.5/52.0 | 18.5 | 85.2 | 0.00 % | 4.45 % | 2.93 % | 10.0 |
| AVI Polymers Ltd | 9.42 Cr. | 23.0 | 34.6/9.89 | 3.09 | 19.5 | 0.00 % | 19.4 % | 15.6 % | 10.0 |
| Supreme Petrochem Ltd | 12,684 Cr. | 674 | 982/518 | 41.3 | 118 | 1.48 % | 22.8 % | 17.4 % | 2.00 |
| Signet Industries Ltd | 147 Cr. | 50.0 | 81.8/39.0 | 7.20 | 80.3 | 1.00 % | 13.7 % | 6.88 % | 10.0 |
| Industry Average | 3,698.71 Cr | 169.99 | 52.32 | 83.12 | 0.90% | 14.57% | 13.10% | 7.55 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,485 | 1,235 | 1,180 | 1,387 | 1,225 | 1,278 | 1,188 | 1,563 | 1,573 | 1,506 | 1,405 | 1,539 | 1,387 |
| Expenses | 1,234 | 1,156 | 1,061 | 1,179 | 1,135 | 1,171 | 1,093 | 1,388 | 1,412 | 1,380 | 1,306 | 1,394 | 1,272 |
| Operating Profit | 252 | 79 | 119 | 208 | 90 | 106 | 95 | 175 | 161 | 125 | 99 | 145 | 115 |
| OPM % | 17% | 6% | 10% | 15% | 7% | 8% | 8% | 11% | 10% | 8% | 7% | 9% | 8% |
| Other Income | 12 | 12 | 14 | 21 | 18 | 16 | 16 | 19 | 23 | 17 | 17 | 19 | 15 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 3 | 3 | 3 | 3 | 3 |
| Depreciation | 11 | 11 | 11 | 14 | 14 | 14 | 15 | 16 | 16 | 17 | 17 | 17 | 18 |
| Profit before tax | 252 | 78 | 121 | 215 | 94 | 106 | 92 | 177 | 164 | 122 | 96 | 143 | 109 |
| Tax % | 25% | 24% | 26% | 26% | 26% | 26% | 27% | 26% | 26% | 26% | 26% | 25% | 25% |
| Net Profit | 189 | 60 | 90 | 159 | 69 | 78 | 68 | 132 | 122 | 90 | 71 | 107 | 81 |
| EPS in Rs | 10.06 | 3.18 | 4.78 | 8.47 | 3.68 | 4.15 | 3.60 | 6.99 | 6.49 | 4.80 | 3.79 | 5.68 | 4.30 |
Last Updated: August 1, 2025, 10:50 am
Below is a detailed analysis of the quarterly data for Supreme Petrochem Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1,387.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,539.00 Cr. (Mar 2025) to 1,387.00 Cr., marking a decrease of 152.00 Cr..
- For Expenses, as of Jun 2025, the value is 1,272.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,394.00 Cr. (Mar 2025) to 1,272.00 Cr., marking a decrease of 122.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 115.00 Cr.. The value appears to be declining and may need further review. It has decreased from 145.00 Cr. (Mar 2025) to 115.00 Cr., marking a decrease of 30.00 Cr..
- For OPM %, as of Jun 2025, the value is 8.00%. The value appears to be declining and may need further review. It has decreased from 9.00% (Mar 2025) to 8.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 4.00 Cr..
- For Interest, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Depreciation, as of Jun 2025, the value is 18.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 109.00 Cr.. The value appears to be declining and may need further review. It has decreased from 143.00 Cr. (Mar 2025) to 109.00 Cr., marking a decrease of 34.00 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00%.
- For Net Profit, as of Jun 2025, the value is 81.00 Cr.. The value appears to be declining and may need further review. It has decreased from 107.00 Cr. (Mar 2025) to 81.00 Cr., marking a decrease of 26.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 4.30. The value appears to be declining and may need further review. It has decreased from 5.68 (Mar 2025) to 4.30, marking a decrease of 1.38.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:20 am
| Metric | Jun 2014 | Jun 2015 | Mar 2016n n 9m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,264 | 2,653 | 2,068 | 2,919 | 3,027 | 3,194 | 2,724 | 3,185 | 5,032 | 5,287 | 5,253 | 6,023 | 5,836 |
| Expenses | 3,175 | 2,559 | 1,964 | 2,621 | 2,830 | 3,100 | 2,576 | 2,511 | 4,126 | 4,626 | 4,780 | 5,488 | 5,353 |
| Operating Profit | 90 | 93 | 104 | 297 | 196 | 93 | 148 | 674 | 907 | 661 | 473 | 535 | 484 |
| OPM % | 3% | 4% | 5% | 10% | 6% | 3% | 5% | 21% | 18% | 12% | 9% | 9% | 8% |
| Other Income | 6 | 3 | 3 | 7 | 8 | 10 | 12 | 16 | 30 | 59 | 65 | 73 | 68 |
| Interest | 23 | 17 | 5 | 5 | 5 | 4 | 6 | 7 | 7 | 6 | 10 | 15 | 12 |
| Depreciation | 29 | 24 | 17 | 22 | 21 | 23 | 36 | 39 | 42 | 47 | 59 | 68 | 70 |
| Profit before tax | 44 | 56 | 85 | 278 | 179 | 76 | 118 | 644 | 888 | 667 | 468 | 525 | 470 |
| Tax % | 31% | 37% | 33% | 35% | 35% | 35% | 13% | 26% | 25% | 25% | 26% | 26% | |
| Net Profit | 31 | 36 | 57 | 179 | 116 | 49 | 103 | 477 | 663 | 498 | 346 | 391 | 350 |
| EPS in Rs | 1.58 | 1.85 | 2.96 | 9.30 | 6.02 | 2.55 | 5.32 | 25.40 | 35.28 | 26.49 | 18.43 | 20.77 | 18.57 |
| Dividend Payout % | 47% | 41% | 51% | 24% | 37% | 59% | 52% | 30% | 22% | 42% | 49% | 48% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -35.20% | -57.76% | 110.20% | 363.11% | 38.99% | -24.89% | -30.52% | 13.01% |
| Change in YoY Net Profit Growth (%) | 0.00% | -22.56% | 167.96% | 252.90% | -324.11% | -63.88% | -5.64% | 43.53% |
Supreme Petrochem Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 17% |
| 3 Years: | 6% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 29% |
| 3 Years: | -17% |
| TTM: | -12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 49% |
| 3 Years: | 26% |
| 1 Year: | -10% |
| Return on Equity | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 29% |
| 3 Years: | 20% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 1:40 pm
Balance Sheet
Last Updated: December 4, 2025, 2:03 am
| Month | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 94 | 38 | 38 | 38 | 38 | 38 |
| Reserves | 268 | 280 | 318 | 486 | 549 | 546 | 577 | 971 | 1,478 | 1,806 | 1,982 | 2,194 | 2,182 |
| Borrowings | 32 | 0 | 0 | 0 | 0 | 0 | 29 | 41 | 37 | 17 | 114 | 130 | 140 |
| Other Liabilities | 587 | 505 | 523 | 548 | 650 | 578 | 552 | 649 | 725 | 870 | 932 | 1,087 | 922 |
| Total Liabilities | 984 | 881 | 938 | 1,130 | 1,296 | 1,221 | 1,255 | 1,755 | 2,278 | 2,731 | 3,065 | 3,448 | 3,282 |
| Fixed Assets | 371 | 345 | 333 | 337 | 333 | 331 | 371 | 359 | 337 | 527 | 769 | 813 | 1,486 |
| CWIP | 4 | 4 | 10 | 13 | 10 | 24 | 8 | 9 | 179 | 108 | 233 | 582 | 41 |
| Investments | 0 | 0 | 0 | 0 | 111 | 251 | 135 | 470 | 484 | 563 | 572 | 435 | 235 |
| Other Assets | 608 | 532 | 595 | 780 | 842 | 615 | 741 | 917 | 1,279 | 1,534 | 1,492 | 1,618 | 1,520 |
| Total Assets | 984 | 881 | 938 | 1,130 | 1,296 | 1,221 | 1,255 | 1,755 | 2,278 | 2,731 | 3,065 | 3,448 | 3,282 |
Below is a detailed analysis of the balance sheet data for Supreme Petrochem Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 38.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 38.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,182.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,194.00 Cr. (Mar 2025) to 2,182.00 Cr., marking a decrease of 12.00 Cr..
- For Borrowings, as of Sep 2025, the value is 140.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 130.00 Cr. (Mar 2025) to 140.00 Cr., marking an increase of 10.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 922.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,087.00 Cr. (Mar 2025) to 922.00 Cr., marking a decrease of 165.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,282.00 Cr.. The value appears to be improving (decreasing). It has decreased from 3,448.00 Cr. (Mar 2025) to 3,282.00 Cr., marking a decrease of 166.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,486.00 Cr.. The value appears strong and on an upward trend. It has increased from 813.00 Cr. (Mar 2025) to 1,486.00 Cr., marking an increase of 673.00 Cr..
- For CWIP, as of Sep 2025, the value is 41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 582.00 Cr. (Mar 2025) to 41.00 Cr., marking a decrease of 541.00 Cr..
- For Investments, as of Sep 2025, the value is 235.00 Cr.. The value appears to be declining and may need further review. It has decreased from 435.00 Cr. (Mar 2025) to 235.00 Cr., marking a decrease of 200.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,520.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,618.00 Cr. (Mar 2025) to 1,520.00 Cr., marking a decrease of 98.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,282.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,448.00 Cr. (Mar 2025) to 3,282.00 Cr., marking a decrease of 166.00 Cr..
Notably, the Reserves (2,182.00 Cr.) exceed the Borrowings (140.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Jun 2014 | Jun 2015 | Mar 2016n n 9m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 58.00 | 93.00 | 104.00 | 297.00 | 196.00 | 93.00 | 119.00 | 633.00 | 870.00 | 644.00 | 359.00 | 405.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 38 | 33 | 50 | 38 | 36 | 33 | 33 | 44 | 30 | 25 | 27 | 24 |
| Inventory Days | 22 | 29 | 37 | 46 | 44 | 31 | 40 | 51 | 29 | 55 | 39 | 50 |
| Days Payable | 60 | 61 | 83 | 65 | 80 | 60 | 74 | 90 | 50 | 66 | 66 | 66 |
| Cash Conversion Cycle | -0 | 1 | 3 | 19 | -0 | 3 | -0 | 4 | 8 | 14 | 0 | 8 |
| Working Capital Days | 1 | 3 | 8 | 22 | 12 | 5 | 5 | 19 | 8 | 19 | 1 | 4 |
| ROCE % | 16% | 19% | 22% | 57% | 30% | 12% | 18% | 72% | 66% | 37% | 22% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HSBC Small Cap Fund | 3,365,768 | 1.53 | 252.55 | N/A | N/A | N/A |
| ICICI Prudential Smallcap Fund | 1,279,661 | 1.11 | 96.02 | 329,871 | 2025-12-08 02:31:51 | 287.93% |
| Mahindra Manulife Small Cap Fund | 1,019,078 | 1.78 | 76.47 | N/A | N/A | N/A |
| ICICI Prudential Childrens Fund | 341,213 | 1.81 | 25.6 | N/A | N/A | N/A |
| ITI ELSS Tax Saver Fund | 74,485 | 1.25 | 5.59 | N/A | N/A | N/A |
| ICICI Prudential Commodities Fund | 26,302 | 0.06 | 1.97 | N/A | N/A | N/A |
| ICICI Prudential Multicap Fund | 4,559 | 0 | 0.34 | N/A | N/A | N/A |
| ICICI Prudential Manufacturing Fund | 2,449 | 0 | 0.18 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 4.00 | 10.00 |
| Basic EPS (Rs.) | 20.77 | 18.43 | 26.49 | 70.54 | 50.63 |
| Diluted EPS (Rs.) | 20.77 | 18.43 | 26.49 | 70.54 | 50.63 |
| Cash EPS (Rs.) | 24.38 | 21.59 | 28.97 | 75.00 | 54.95 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 118.66 | 107.38 | 98.06 | 161.20 | 113.26 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 118.66 | 107.38 | 98.06 | 161.20 | 113.26 |
| Dividend / Share (Rs.) | 10.00 | 9.00 | 9.00 | 7.20 | 15.00 |
| Revenue From Operations / Share (Rs.) | 320.32 | 279.37 | 281.17 | 535.23 | 338.77 |
| PBDIT / Share (Rs.) | 32.22 | 28.45 | 38.13 | 99.54 | 73.41 |
| PBIT / Share (Rs.) | 28.60 | 25.28 | 35.66 | 95.09 | 69.25 |
| PBT / Share (Rs.) | 27.94 | 24.90 | 35.46 | 94.43 | 68.47 |
| Net Profit / Share (Rs.) | 20.77 | 18.43 | 26.49 | 70.54 | 50.78 |
| PBDIT Margin (%) | 10.05 | 10.18 | 13.56 | 18.59 | 21.66 |
| PBIT Margin (%) | 8.92 | 9.05 | 12.68 | 17.76 | 20.44 |
| PBT Margin (%) | 8.72 | 8.91 | 12.61 | 17.64 | 20.21 |
| Net Profit Margin (%) | 6.48 | 6.59 | 9.42 | 13.18 | 14.99 |
| Return on Networth / Equity (%) | 17.50 | 17.16 | 27.01 | 43.76 | 44.84 |
| Return on Capital Employeed (%) | 22.53 | 21.94 | 35.49 | 56.82 | 57.42 |
| Return On Assets (%) | 11.32 | 11.30 | 18.23 | 29.11 | 27.20 |
| Asset Turnover Ratio (%) | 1.85 | 1.81 | 2.11 | 2.50 | 2.12 |
| Current Ratio (X) | 1.91 | 2.23 | 2.41 | 2.48 | 2.20 |
| Quick Ratio (X) | 1.24 | 1.69 | 1.64 | 2.05 | 1.68 |
| Inventory Turnover Ratio (X) | 6.45 | 5.77 | 6.79 | 8.74 | 5.55 |
| Dividend Payout Ratio (NP) (%) | 45.74 | 48.84 | 33.97 | 23.38 | 7.87 |
| Dividend Payout Ratio (CP) (%) | 38.96 | 41.68 | 31.06 | 22.00 | 7.27 |
| Earning Retention Ratio (%) | 54.26 | 51.16 | 66.03 | 76.62 | 92.13 |
| Cash Earning Retention Ratio (%) | 61.04 | 58.32 | 68.94 | 78.00 | 92.73 |
| Interest Coverage Ratio (X) | 48.80 | 74.07 | 200.52 | 149.99 | 94.93 |
| Interest Coverage Ratio (Post Tax) (X) | 32.46 | 48.98 | 140.30 | 107.29 | 66.68 |
| Enterprise Value (Cr.) | 11337.80 | 11193.68 | 6625.88 | 8246.18 | 3825.67 |
| EV / Net Operating Revenue (X) | 1.88 | 2.13 | 1.25 | 1.64 | 1.20 |
| EV / EBITDA (X) | 18.72 | 20.93 | 9.24 | 8.81 | 5.54 |
| MarketCap / Net Operating Revenue (X) | 1.96 | 2.23 | 1.32 | 1.73 | 1.23 |
| Retention Ratios (%) | 54.25 | 51.15 | 66.02 | 76.61 | 92.12 |
| Price / BV (X) | 5.29 | 5.80 | 3.78 | 5.74 | 3.69 |
| Price / Net Operating Revenue (X) | 1.96 | 2.23 | 1.32 | 1.73 | 1.23 |
| EarningsYield | 0.03 | 0.02 | 0.07 | 0.07 | 0.12 |
After reviewing the key financial ratios for Supreme Petrochem Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 20.77. This value is within the healthy range. It has increased from 18.43 (Mar 24) to 20.77, marking an increase of 2.34.
- For Diluted EPS (Rs.), as of Mar 25, the value is 20.77. This value is within the healthy range. It has increased from 18.43 (Mar 24) to 20.77, marking an increase of 2.34.
- For Cash EPS (Rs.), as of Mar 25, the value is 24.38. This value is within the healthy range. It has increased from 21.59 (Mar 24) to 24.38, marking an increase of 2.79.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 118.66. It has increased from 107.38 (Mar 24) to 118.66, marking an increase of 11.28.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 118.66. It has increased from 107.38 (Mar 24) to 118.66, marking an increase of 11.28.
- For Dividend / Share (Rs.), as of Mar 25, the value is 10.00. This value exceeds the healthy maximum of 3. It has increased from 9.00 (Mar 24) to 10.00, marking an increase of 1.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 320.32. It has increased from 279.37 (Mar 24) to 320.32, marking an increase of 40.95.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 32.22. This value is within the healthy range. It has increased from 28.45 (Mar 24) to 32.22, marking an increase of 3.77.
- For PBIT / Share (Rs.), as of Mar 25, the value is 28.60. This value is within the healthy range. It has increased from 25.28 (Mar 24) to 28.60, marking an increase of 3.32.
- For PBT / Share (Rs.), as of Mar 25, the value is 27.94. This value is within the healthy range. It has increased from 24.90 (Mar 24) to 27.94, marking an increase of 3.04.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 20.77. This value is within the healthy range. It has increased from 18.43 (Mar 24) to 20.77, marking an increase of 2.34.
- For PBDIT Margin (%), as of Mar 25, the value is 10.05. This value is within the healthy range. It has decreased from 10.18 (Mar 24) to 10.05, marking a decrease of 0.13.
- For PBIT Margin (%), as of Mar 25, the value is 8.92. This value is below the healthy minimum of 10. It has decreased from 9.05 (Mar 24) to 8.92, marking a decrease of 0.13.
- For PBT Margin (%), as of Mar 25, the value is 8.72. This value is below the healthy minimum of 10. It has decreased from 8.91 (Mar 24) to 8.72, marking a decrease of 0.19.
- For Net Profit Margin (%), as of Mar 25, the value is 6.48. This value is within the healthy range. It has decreased from 6.59 (Mar 24) to 6.48, marking a decrease of 0.11.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.50. This value is within the healthy range. It has increased from 17.16 (Mar 24) to 17.50, marking an increase of 0.34.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.53. This value is within the healthy range. It has increased from 21.94 (Mar 24) to 22.53, marking an increase of 0.59.
- For Return On Assets (%), as of Mar 25, the value is 11.32. This value is within the healthy range. It has increased from 11.30 (Mar 24) to 11.32, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.85. It has increased from 1.81 (Mar 24) to 1.85, marking an increase of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 1.91. This value is within the healthy range. It has decreased from 2.23 (Mar 24) to 1.91, marking a decrease of 0.32.
- For Quick Ratio (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has decreased from 1.69 (Mar 24) to 1.24, marking a decrease of 0.45.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.45. This value is within the healthy range. It has increased from 5.77 (Mar 24) to 6.45, marking an increase of 0.68.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 45.74. This value is within the healthy range. It has decreased from 48.84 (Mar 24) to 45.74, marking a decrease of 3.10.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 38.96. This value is within the healthy range. It has decreased from 41.68 (Mar 24) to 38.96, marking a decrease of 2.72.
- For Earning Retention Ratio (%), as of Mar 25, the value is 54.26. This value is within the healthy range. It has increased from 51.16 (Mar 24) to 54.26, marking an increase of 3.10.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 61.04. This value is within the healthy range. It has increased from 58.32 (Mar 24) to 61.04, marking an increase of 2.72.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 48.80. This value is within the healthy range. It has decreased from 74.07 (Mar 24) to 48.80, marking a decrease of 25.27.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 32.46. This value is within the healthy range. It has decreased from 48.98 (Mar 24) to 32.46, marking a decrease of 16.52.
- For Enterprise Value (Cr.), as of Mar 25, the value is 11,337.80. It has increased from 11,193.68 (Mar 24) to 11,337.80, marking an increase of 144.12.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.88. This value is within the healthy range. It has decreased from 2.13 (Mar 24) to 1.88, marking a decrease of 0.25.
- For EV / EBITDA (X), as of Mar 25, the value is 18.72. This value exceeds the healthy maximum of 15. It has decreased from 20.93 (Mar 24) to 18.72, marking a decrease of 2.21.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.96. This value is within the healthy range. It has decreased from 2.23 (Mar 24) to 1.96, marking a decrease of 0.27.
- For Retention Ratios (%), as of Mar 25, the value is 54.25. This value is within the healthy range. It has increased from 51.15 (Mar 24) to 54.25, marking an increase of 3.10.
- For Price / BV (X), as of Mar 25, the value is 5.29. This value exceeds the healthy maximum of 3. It has decreased from 5.80 (Mar 24) to 5.29, marking a decrease of 0.51.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.96. This value is within the healthy range. It has decreased from 2.23 (Mar 24) to 1.96, marking a decrease of 0.27.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Supreme Petrochem Ltd:
- Net Profit Margin: 6.48%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.53% (Industry Average ROCE: 14.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.5% (Industry Average ROE: 13.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 32.46
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.24
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 41.3 (Industry average Stock P/E: 52.32)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.48%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Petrochemicals - Polymers | Solitaire Corporate Park, Building No. 11, Mumbai Maharashtra 400093 | investorhelpline@spl.co.in http://www.supremepetrochem.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. M P Taparia | Chairperson |
| Mr. Rajan B Raheja | Non Independent Director |
| Mr. B L Taparia | Non Independent Director |
| Mr. S J Taparia | Non Independent Director |
| Mr. Rajeev M Pandia | Independent Director |
| Mr. Akshay R Raheja | Non Independent Director |
| Mr. Anup Kumar Ghosh | Independent Director |
| Mr. Basavaraj N Bankapur | Independent Director |
| Mr. Sanjay R Chougule | Independent Director |
| Ms. Rita A Teaotia | Independent Director |
| Ms. Mona N Desai | Independent Director |
FAQ
What is the intrinsic value of Supreme Petrochem Ltd?
Supreme Petrochem Ltd's intrinsic value (as of 09 December 2025) is 688.42 which is 2.14% higher the current market price of 674.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 12,684 Cr. market cap, FY2025-2026 high/low of 982/518, reserves of ₹2,182 Cr, and liabilities of 3,282 Cr.
What is the Market Cap of Supreme Petrochem Ltd?
The Market Cap of Supreme Petrochem Ltd is 12,684 Cr..
What is the current Stock Price of Supreme Petrochem Ltd as on 09 December 2025?
The current stock price of Supreme Petrochem Ltd as on 09 December 2025 is 674.
What is the High / Low of Supreme Petrochem Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Supreme Petrochem Ltd stocks is 982/518.
What is the Stock P/E of Supreme Petrochem Ltd?
The Stock P/E of Supreme Petrochem Ltd is 41.3.
What is the Book Value of Supreme Petrochem Ltd?
The Book Value of Supreme Petrochem Ltd is 118.
What is the Dividend Yield of Supreme Petrochem Ltd?
The Dividend Yield of Supreme Petrochem Ltd is 1.48 %.
What is the ROCE of Supreme Petrochem Ltd?
The ROCE of Supreme Petrochem Ltd is 22.8 %.
What is the ROE of Supreme Petrochem Ltd?
The ROE of Supreme Petrochem Ltd is 17.4 %.
What is the Face Value of Supreme Petrochem Ltd?
The Face Value of Supreme Petrochem Ltd is 2.00.